RBC Capital analysts reaffirmed their Outperform rating on the stock in a note Tuesday, emphasizing that President Trump's recent executive order on wind leasing and permitting is unlikely to have a ...

RBC Capital Markets adjusted its stance on CF Industries Holdings Inc. (NYSE:CF), downgrading the stock from 'Outperform' to ...

Tuesday, shares of Carnarvon Energy Ltd (CVN:AU) (OTC: CVONF) experienced a shift in perspective from analysts at RBC Capital ...

Syndax Pharmaceuticals struggles with competitive pressures and market skepticism despite promising drugs and strong cash position. Read more on SNDX here.

In a report released today, Luca Issi from RBC Capital maintained a Buy rating on uniQure (QURE – Research Report), with a price target of ...

In a report released today, Luca Issi from RBC Capital maintained a Buy rating on Alnylam Pharma (ALNY – Research Report), with a price target ...

SAGE Therapeutics Inc (SAGE) stock saw a modest uptick, ending the day at $7.08 which represents a slight increase of $0.11 or 1.58% from the prior close of $6.97. The stock opened at $7.02 and ...

CoStar Group Inc (CSGP) stock saw a modest uptick, ending the day at $73.85 which represents a slight increase of $0.43 or 0.59% from the prior close of $73.42. The stock opened at $75.06 and touched ...

The UK bank's stock price is already up 95 per cent over the last year, making it one of the best performing stocks on the ...

U.S. stock trading hedge funds kicked off the week with gross leverage levels in their highest range since 2010.

Hedge funds have positioned for Donald Trump's U.S. presidency with their highest levels of borrowing since 2010, while ...